ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

NCI T Use Ames Test In Carcinogenesis Testing Program

December 3, 1976

In Brief: Lee Helman To Head NCI Pediatric Branch; HHS to Hear From Academic Health Centers

August 22, 1997

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Report Questions Effectiveness Of Bimanual Pelvic Exam

March 31, 2006